NAGE
Niagen Bioscience
NAGE
NAGE
55 hedge funds and large institutions have $17.7M invested in Niagen Bioscience in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less call options, than puts
Call options by funds: $70K | Put options by funds: $97K
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Holders
55
Holding in Top 10
–
Calls
$70K
Puts
$97K
Top Buyers
| 1 | +$58.7K | |
| 2 | +$52.3K | |
| 3 | +$45.2K | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$40.5K |
| 5 |
TCM
Tieton Capital Management
Yakima,
Washington
|
+$33.7K |
Top Sellers
| 1 | -$364K | |
| 2 | -$167K | |
| 3 | -$159K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$132K |
| 5 |
D.E. Shaw & Co
New York
|
-$91.6K |